145 145 Pill - yellow capsule/oblong, 18mm
Pill with imprint 145 145 is Yellow, Capsule/Oblong and has been identified as Rivastigmine Tartrate 1.5 mg. It is supplied by Sun Pharmaceutical Industries Inc.
Rivastigmine is used in the treatment of Parkinson's Disease; Alzheimer's Disease and belongs to the drug class cholinesterase inhibitors. There is no proven risk in humans during pregnancy. Rivastigmine 1.5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 145 145
Rivastigmine Tartrate
- Imprint
- 145 145
- Strength
- 1.5 mg
- Color
- Yellow
- Size
- 18.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Cholinesterase inhibitors
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Sun Pharmaceutical Industries Inc.
- Inactive Ingredients
-
magnesium stearate,
microcrystalline cellulose,
silicon dioxide,
gelatin,
titanium dioxide,
D&C Red No. 28,
D&C Yellow No. 10,
FD&C Yellow No. 6,
shellac,
alcohol,
butyl alcohol,
propylene glycol,
ammonia,
potassium hydroxide,
ferrosoferric oxide
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 62756-0145 | Sun Pharmaceutical Industries Inc. |
| 68084-0550 (Discontinued) | Amerisource Health Services |
Related images for "145 145"
More about rivastigmine
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (39)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: cholinesterase inhibitors
Patient resources
- Rivastigmine drug information
- Rivastigmine transdermal
- Rivastigmine (Oral) (Advanced Reading)
- Rivastigmine (Transdermal) (Advanced Reading)
- Rivastigmine Capsules
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.